Naslov: | Worldwide perspectives on venom allergy |
---|
Avtorji: | ID Korošec, Peter, Klinika Golnik (Avtor) ID Jakob, Thilo (Avtor) ID Harb, Harfi (Avtor) ID Heddle, Robert (Avtor) ID Karabus, Sarah (Avtor) ID Lima Zollner, Ricardo de (Avtor) ID Šelb, Julij, Klinika Golnik (Avtor) ID Yu-Hor Thong, Bernard (Avtor) ID Zaitoun, Fares (Avtor) ID Golden, David B. K. (Avtor) ID Levin, Michael (Avtor) |
Datoteke: | PDF - Predstavitvena datoteka, prenos (313,42 KB) MD5: C7FF2C15568B3980F7C9008F4E075B1F
URL - Izvorni URL, za dostop obiščite https://www.worldallergyorganizationjournal.org/article/S1939-4551(19)31221-9/fulltext
|
---|
Jezik: | Angleški jezik |
---|
Tipologija: | 1.02 - Pregledni znanstveni članek |
---|
Organizacija: | UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
---|
Povzetek: | Venom immunotherapy is the standard of care for people with severe reactions and has been proven to reduce risk of future anaphylactic events. There is a moral imperative to ensure production, supply and worldwide availability of locally relevant, registered, standardized commercial venom extracts for diagnosis and treatment. Insects causing severe immediate allergic reactions vary by region worldwide. The most common culprits include honeybees (Apis mellifera), social wasps including yellow jackets (Vespula and Dolichovespula), paper wasps (Polistes) and hornets (Vespa), stinging ants (Solenopsis, Myrmecia, Pachycondyla, and Pogonomyrmex), and bumblebees (Bombus). Insects with importance in specific areas of the world include the Australian tick (Ixodes holocyclus), the kissing bug (Triatoma spp), horseflies (Tabanus spp), and mosquitoes (Aedes, Culex, Anopheles). Reliable access to high quality venom immunotherapy to locally relevant allergens is not available throughout the world. Many current commercially available therapeutic vaccines have deficiencies, are not suitable for, or are unavailable in vast areas of the globe. New products are required to replace products that are unstandardized or inadequate, particularly whole-body extract products. New products are required for insects in which no current treatment options exist. Venom immunotherapy should be promoted throughout the world and the provision thereof be supported by health authorities, regulatory authorities and all sectors of the health care service. |
---|
Ključne besede: | allergy and immunology, venoms, Hymenoptera, bee venoms, wasp venoms, insecta, ants hornet, bumblebee, mosquitoes, venom immunotherapy, immunologic desensitization |
---|
Status publikacije: | Objavljeno |
---|
Verzija publikacije: | Objavljena publikacija |
---|
Kraj izida: | Velika Britanija |
---|
Založnik: | Elsevier |
---|
Leto izida: | 2019 |
---|
Št. strani: | str. 1-11 |
---|
Številčenje: | Vol. 12, iss. 10 |
---|
PID: | 20.500.12556/DiRROS-12435 ![Povezava se odpre v novem oknu Novo okno](teme/dirros/img/NovoOkno.png) |
---|
UDK: | 616-097 |
---|
ISSN pri članku: | 1939-4551 |
---|
DOI: | 10.1016/j.waojou.2019.100067 ![Povezava se odpre v novem oknu Novo okno](teme/dirros/img/NovoOkno.png) |
---|
COBISS.SI-ID: | 2048568945 ![Povezava se odpre v novem oknu Novo okno](teme/dirros/img/NovoOkno.png) |
---|
Avtorske pravice: | © 2019 The Authors |
---|
Opomba: | Soavtor iz Slovenije: Julij Selb;
"Korosec and Jakob were joint first authors" --> str. 1;
Nasl. z nasl. zaslona;
Opis vira z dne 8. 11. 2019;
Št. članka: 10067;
|
---|
Datum objave v DiRROS: | 23.09.2020 |
---|
Število ogledov: | 2050 |
---|
Število prenosov: | 1169 |
---|
Metapodatki: | ![Izvoz v DC-RDF DC-RDF](teme/dirros/img/icon_dc_rdf.gif) |
---|
:
|
Kopiraj citat |
---|
| | | Objavi na: | ![Bookmark and Share](teme/dirros/img/addtoany.png) |
---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |